Myelin makes artificial intelligence a social innovation tool

Marc-Olivier thinks artificial intelligence (AI) can be a solution to human problems and can innovate health promotion.

myelin team

Providing a digital structure to social help

Marc-Olivier Schüle, along with his two partners, Marise Bonenfant and Francois Menet, is introducing Myelin, a new innovative startup that gives access to the best, most accurate information on autism. The AI tool adapts its answers to your level of knowledge and the type of question you want to ask.

Myelin is not inventing anything new, it innovates the way actual knowledge is processed, structured and delivered.

When you look at current information on Google related to autism, it is non-professional, non-official and… probably false. Myelin will be a source of knowledge supported by recognized institutions like the School of Psycho-Education from Université de Montreal, Quebec Federation on Autism, Ivado (the Institute for Data Valorization) and many other.

Academic excellence at the service of social intervention 

Marc-Olivier knows what he is talking about: he has years of experience in psychosocial intervention that made him realize the need for a serious and reliable foundation to build trusting relations with patients and their parents. At the same time, his academic experience (he is doing a PhD at Université de Montreal) reveals that the latest advances in research are unfortunately buried in universities’ intranet servers.

There are over 2000 articles published every day on mental health. How can we all process it and make it useful? Psychosocial actors need secure and reliable tools so we can spend more time on working on our relation with parents and children

From a prototype to a social artificial intelligence tool  


This is only the beginning of the story: Marc-Olivier’s speech at TedX Laval was viewed over 40,000 times on Youtube (an all-time record) so it is undeniable that people believe in artificial intelligence applied to health issues.

The prototype is now ready for autism but Myelin wants to touch on other subjects in the future: ADHDH, anxiety, Alzheimer… to provide the general public with the proper tools to make a free and informed choice in their lives.

With a successful crowdfunding campaign on La Ruche, support from prestigious academic, medical, institutional and entrepreneurial actors and – last but not least – a dedicated and passionate team of entrepreneurs, Myelin is clearly innovating the startup scene.